ProMIS Neurosciences
PMN
9 hedge funds and large institutions have $1.8M invested in ProMIS Neurosciences in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 16 closing their positions.
7% less ownership
Funds ownership: 19.29% → 12.29% (-7%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
58% less capital invested
Capital invested by funds: $4.25M → $1.8M (-$2.45M)
61% less funds holding
Funds holding: 23 → 9 (-14)
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$13.2K |
| 2 |
DEM
Disciplined Equity Management
Neptune Beach,
Florida
|
+$9.75K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$3.12K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$195 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.26M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$72.3K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$28.8K |
| 4 |
HF
HRT Financial
New York
|
-$28K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$13.1K |
PMN Hedge Fund Activity: Q4 2025 in Review
9 of the 8,276 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q4 2025, worth a combined $1.8M — down 58% from $4.25M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PMN and 2 opened new positions — a net loss of 14 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $13.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.26M sold.
- 9 institutional investors held ProMIS Neurosciences (PMN) as of Q4 2025, down from 23 in Q3 2025.
- Funds reported $1.8M of ProMIS Neurosciences stock for Q4 2025, down 58% quarter-over-quarter.
- 2 funds opened new ProMIS Neurosciences positions in Q4 2025 and 16 closed out, a net change of -14 holders.
- The largest ProMIS Neurosciences buyer in Q4 2025 was UBS Group, an estimated $13.2K added.
- The largest ProMIS Neurosciences seller in Q4 2025 was Armistice Capital, an estimated $1.26M sold.
Based on aggregated 13F filings for Q4 2025.